One Year Study to Evaluate the Long-term Safety and Tolerability of Dupilumab in Pediatric Patients With Asthma Who Participated in a Previous Dupilumab Asthma Clinical Study
Phase of Trial: Phase III
Latest Information Update: 05 Dec 2019
Price : $35 *
At a glance
- Drugs Dupilumab (Primary) ; Antiasthmatics; Prednisolone; Prednisolone; Prednisone; Prednisone
- Indications Asthma
- Focus Adverse reactions
- Acronyms Liberty Asthma Excursion
- Sponsors Sanofi
- 09 Oct 2019 Planned End Date changed from 1 Dec 2026 to 1 Jun 2027.
- 09 Oct 2019 Planned primary completion date changed from 1 Dec 2026 to 1 Jun 2027.
- 12 Jul 2019 Planned End Date changed from 15 Apr 2026 to 1 Dec 2026.